EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Single and Combined Impact of Semaglutide, Tirzepatide, and Metformin on β-Cell Maintenance and Function Under High-Glucose–High-Lipid Conditions: A Comparative Study

Esmaeel Ghasemi Gojani iD, Bo Wang iD, Dongping Li, Olga Kovalchuk, Igor Kovalchuk iD

International Journal of Molecular Sciences · 06.01.2025 · 26 (1) · 421

DOI: 10.3390/ijms26010421 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 06.01.2025. Verfasst von Esmaeel Ghasemi Gojani und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, University of Lethbridge, Lethbridge, AB T1K 3M4, Canada. Hauptthemen laut MEDLINE: Metformin, Glucagon-Like Peptides, Insulin-Secreting Cells, Glucose. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Mitacs.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Type 2 diabetes (T2D), the most common form, is marked by insulin resistance and β-cell failure. β-cell dysfunction under high-glucose–high-lipid (HG-HL) conditions is a key contributor to the progression of T2D. This study evaluates the comparative effects of 10 nM semaglutide, 10 nM tirzepatide, and 1 mM metformin, both alone and in combination, on INS-1 β-cell maintenance and function under HG-HL conditions. INS-1 cells were pretreated for 2 h with single doses of metformin (1 mM), semaglutide (10 nM), tirzepatide (10 nM), or combinations of 1 mM metformin with either 10 nM semaglutide or 10 nM tirzepatide, followed by 48 h of HG-HL stimulation. The results indicate that combining 1 mM metformin with either 10 nM semaglutide or 10 nM tirzepatide significantly enhances the effects of 10 nM semaglutide and 10 nM tirzepatide on HG-HL-induced apoptosis and dysregulated cell cycle. Specifically, the combination treatments demonstrated superior restoration of glucose-stimulated insulin secretion (GSIS) functionality compared to 1 mM metformin, 10 nM semaglutide, and 10 nM tirzepatide.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MetforminGlucagon-Like PeptidesInsulin-Secreting CellsGlucoseHypoglycemic AgentsAnimalsRatsApoptosisDiabetes Mellitus, Type 2Insulin SecretionCell LineLipidsTirzepatideGlucagon-Like Peptide 1Semaglutide

Stichwörter der Autor:innen

HG-HL conditionsmetforminsemaglutidetirzepatideβ-cells

Substanzen

MetforminGlucagon-Like PeptidesGlucoseHypoglycemic AgentsLipidsTirzepatideGlucagon-Like Peptide 1Semaglutide

Autor:innen und Institutionen

  • Department of Biological Sciences, University of Lethbridge, Lethbridge, AB T1K 3M4, Canada.

ORCID-Profile: Esmaeel Ghasemi Gojani, Bo Wang, Igor Kovalchuk

Förderung

  • Mitacs

Zitieren

APA

Gojani, E. G., Wang, B., Li, D., Kovalchuk, O., & Kovalchuk, I. (2025). Single and Combined Impact of Semaglutide, Tirzepatide, and Metformin on β-Cell Maintenance and Function Under High-Glucose–High-Lipid Conditions: A Comparative Study. International Journal of Molecular Sciences, 26(1), 421. https://doi.org/10.3390/ijms26010421

Vancouver

Gojani EG, Wang B, Li D, Kovalchuk O, Kovalchuk I. Single and Combined Impact of Semaglutide, Tirzepatide, and Metformin on β-Cell Maintenance and Function Under High-Glucose–High-Lipid Conditions: A Comparative Study. International Journal of Molecular Sciences. 2025;26(1):421. doi:10.3390/ijms26010421

BibTeX
@article{Gojani2025,
  author = {Gojani, Esmaeel Ghasemi and Wang, Bo and Li, Dongping and Kovalchuk, Olga and Kovalchuk, Igor},
  title = {Single and Combined Impact of Semaglutide, Tirzepatide, and Metformin on β-Cell Maintenance and Function Under High-Glucose–High-Lipid Conditions: A Comparative Study},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {1},
  pages = {421},
  doi = {10.3390/ijms26010421}
}
Kostenlos starten →